Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival following lung volume reduction procedures: results from the UK Lung Volume Reduction (UKLVR) registry.

BMJ open respiratory research·2024
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD).

PloS one·2020
Same author

Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study.

International journal of cardiology·2018
Same author

Consumer segmentation and time interval between types of hospital admission: a clinical linkage database study.

Journal of public health (Oxford, England)·2017
Same author

Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study.

QJM : monthly journal of the Association of Physicians·2016
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same journal

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same journal

When symptoms and resting tests disagree in interstitial lung disease: a selective role for cardiopulmonary exercise testing.

The European respiratory journal·2026
Same journal

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same journal

SARS-CoV-2 (E)-protein induces rapid TLR2-mediated T cell activation in mouse lungs revealed by intravital lung microscopy.

The European respiratory journal·2026
Same journal

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Cognitive function in COPD.

J W Dodd1, S V Getov, P W Jones

  • 1Respiratory Medicine, Cardiac and Vascular Sciences, St George's University of London, London, UK. jdodd@sgul.ac.uk

The European Respiratory Journal
|April 2, 2010
PubMed
Summary
This summary is machine-generated.

Cognitive dysfunction is common in chronic obstructive pulmonary disease (COPD), particularly with hypoxemia. This condition may be linked to increased mortality and disability, with limited treatment effects observed.

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jun 14, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

  • Pulmonary Medicine
  • Neurology
  • Cognitive Science

Background:

  • Chronic obstructive pulmonary disease (COPD) is a multi-component disease with significant comorbidities.
  • Cognitive dysfunction is increasingly recognized as a serious consequence of COPD, impacting mortality and disability.
  • The relationship between COPD and cognitive impairment remains poorly understood.

Purpose of the Study:

  • To review the mechanisms of brain injury and cognitive dysfunction in COPD.
  • To examine methods for evaluating cognitive function in COPD patients.
  • To synthesize evidence on the nature and extent of cognitive impairment in COPD.

Main Methods:

  • Literature review focusing on brain injury mechanisms, cognitive assessment methods, and existing evidence on cognitive impairment in COPD.
  • Analysis of factors potentially contributing to cognitive dysfunction, including hypoxemia, hypercapnia, smoking, and comorbidities.
  • Evaluation of associations between cognitive function and mood, fatigue, health status, mortality, and disability.

Main Results:

  • A potential pattern of cognitive dysfunction specific to COPD may exist.
  • Cognitive impairment is mild in patients without hypoxemia but more prevalent with hypoxemia.
  • Factors like hypoxemia, hypercapnia, smoking, and comorbidities do not fully explain cognitive dysfunction in COPD.
  • Cognitive function shows weak or no association with mood, fatigue, or health status.
  • Cognitive dysfunction is potentially linked to increased mortality and disability.
  • Evidence for significant treatment effects on cognitive function in COPD is limited.

Conclusions:

  • Cognitive dysfunction is a significant, complex issue in COPD, potentially independent of known contributing factors.
  • Further research is needed to elucidate specific mechanisms and effective treatments for cognitive impairment in COPD.
  • Recognizing and addressing cognitive dysfunction is crucial for improving outcomes in COPD patients.